Patterns of Alcohol Consumption Among Individuals With Alcohol Use Disorder During the COVID-19 Pandemic and Lockdowns in Germany.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 08 2022
Historique:
entrez: 1 8 2022
pubmed: 2 8 2022
medline: 4 8 2022
Statut: epublish

Résumé

Alcohol consumption (AC) leads to death and disability worldwide. Ongoing discussions on potential negative effects of the COVID-19 pandemic on AC need to be informed by real-world evidence. To examine whether lockdown measures are associated with AC and consumption-related temporal and psychological within-person mechanisms. This quantitative, intensive, longitudinal cohort study recruited 1743 participants from 3 sites from February 20, 2020, to February 28, 2021. Data were provided before and within the second lockdown of the COVID-19 pandemic in Germany: before lockdown (October 2 to November 1, 2020); light lockdown (November 2 to December 15, 2020); and hard lockdown (December 16, 2020, to February 28, 2021). Daily ratings of AC (main outcome) captured during 3 lockdown phases (main variable) and temporal (weekends and holidays) and psychological (social isolation and drinking intention) correlates. Of the 1743 screened participants, 189 (119 [63.0%] male; median [IQR] age, 37 [27.5-52.0] years) with at least 2 alcohol use disorder (AUD) criteria according to the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) yet without the need for medically supervised alcohol withdrawal were included. These individuals provided 14 694 smartphone ratings from October 2020 through February 2021. Multilevel modeling revealed significantly higher AC (grams of alcohol per day) on weekend days vs weekdays (β = 11.39; 95% CI, 10.00-12.77; P < .001). Alcohol consumption was above the overall average on Christmas (β = 26.82; 95% CI, 21.87-31.77; P < .001) and New Year's Eve (β = 66.88; 95% CI, 59.22-74.54; P < .001). During the hard lockdown, perceived social isolation was significantly higher (β = 0.12; 95% CI, 0.06-0.15; P < .001), but AC was significantly lower (β = -5.45; 95% CI, -8.00 to -2.90; P = .001). Independent of lockdown, intention to drink less alcohol was associated with lower AC (β = -11.10; 95% CI, -13.63 to -8.58; P < .001). Notably, differences in AC between weekend and weekdays decreased both during the hard lockdown (β = -6.14; 95% CI, -9.96 to -2.31; P = .002) and in participants with severe AUD (β = -6.26; 95% CI, -10.18 to -2.34; P = .002). This 5-month cohort study found no immediate negative associations of lockdown measures with overall AC. Rather, weekend-weekday and holiday AC patterns exceeded lockdown effects. Differences in AC between weekend days and weekdays evinced that weekend drinking cycles decreased as a function of AUD severity and lockdown measures, indicating a potential mechanism of losing and regaining control. This finding suggests that temporal patterns and drinking intention constitute promising targets for prevention and intervention, even in high-risk individuals.

Identifiants

pubmed: 35913741
pii: 2794813
doi: 10.1001/jamanetworkopen.2022.24641
pmc: PMC9344361
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2224641

Investigateurs

Nina Romanczuk-Seiferth (N)
Andreas Ströhle (A)
Felix Bermpohl (F)
Christine Heim (C)
Anne Beck (A)
Heike Tost (H)
Tobias Banaschewski (T)
Falk Kiefer (F)
Andreas Meyer-Lindenberg (A)
Christian Beste (C)
Tanja Endraß (T)
Stefan Kiebel (S)
Clemens Kirschbaum (C)
Michael Marxen (M)
Wolfgang E Nagel (WE)
Maximilian Pilhatsch (M)
Ann-Kathrin Stock (AK)
Viktoria Arndt (V)
Matthew Belanger (M)
Hao Chen (H)
Sasha Frölich (S)
Filippo Ghin (F)
Caroline Neumer (C)
Sarah Schwöbel (S)
Gabriela Gan (G)
Kristina Schwarz (K)
Stefanie Kunas (S)
Heiner Stuke (H)

Références

Addict Behav. 2018 Aug;83:35-41
pubmed: 29128148
J Epidemiol Community Health. 2012 Jul;66(7):e26
pubmed: 21771817
Addiction. 2000 May;95(5):749-64
pubmed: 10885050
Br J Health Psychol. 2010 Feb;15(Pt 1):1-39
pubmed: 19646331
Front Psychiatry. 2020 Dec 16;11:620612
pubmed: 33391060
Exp Neurol. 2021 Nov;345:113807
pubmed: 34228998
Int J Environ Res Public Health. 2020 Dec 09;17(24):
pubmed: 33316978
Addict Biol. 2020 Mar;25(2):e12866
pubmed: 31859437
Int J Methods Psychiatr Res. 2017 Sep;26(3):
pubmed: 28370786
J Nerv Ment Dis. 1976 Apr;162(4):238-47
pubmed: 1255153
JAMA Psychiatry. 2016 Jun 1;73(6):549-50
pubmed: 27096667
Toxicol Rep. 2021;8:529-535
pubmed: 33723508
Psychol Assess. 2009 Dec;21(4):457-62
pubmed: 19947780
J Affect Disord. 2020 Dec 1;277:810-813
pubmed: 33065821
Lancet Gastroenterol Hepatol. 2020 Oct;5(10):886-887
pubmed: 32763197
JAMA Netw Open. 2020 Sep 1;3(9):e2022942
pubmed: 32990735
Lancet. 2018 Sep 22;392(10152):1015-1035
pubmed: 30146330
JAMA. 2021 Jul 20;326(3):209-211
pubmed: 34190978
Annu Rev Clin Psychol. 2013;9:151-76
pubmed: 23157450
Br J Health Psychol. 2021 May;26(2):624-643
pubmed: 33410229
Addiction. 2005 Jun;100(6):797-805
pubmed: 15918810
JAMA. 2018 Aug 21;320(7):639-640
pubmed: 29852046
N Engl J Med. 1985 Jun 27;312(26):1678-82
pubmed: 4000215

Auteurs

Friederike Deeken (F)

Department of Social and Preventive Medicine, University of Potsdam, Potsdam, Germany.

Markus Reichert (M)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Heidelberg University, Medical Faculty Mannheim, Mannheim, Germany.
Mental mHealth Lab, Department of Sports and Sports Science, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Department of eHealth and Sports Analytics, Faculty of Sports Science, Ruhr-University Bochum, Bochum, Germany.

Hilmar Zech (H)

Department of Psychiatry, Technische Universität Dresden, Dresden, Germany.

Julia Wenzel (J)

Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, corporate member of FreieUniversität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Friederike Wedemeyer (F)

Epilepsy-Center Berlin-Brandenburg, Epilepsy-Clinic Tabor, Bernau, Germany.

Alvaro Aguilera (A)

Center for Information Services and High Performance Computing, Technische Universität Dresden, Dresden, Germany.

Acelya Aslan (A)

Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Patrick Bach (P)

Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Nadja S Bahr (NS)

Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, corporate member of FreieUniversität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Claudia Ebrahimi (C)

Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, corporate member of FreieUniversität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Pascale C Fischbach (PC)

Department of Psychiatry, Technische Universität Dresden, Dresden, Germany.

Marvin Ganz (M)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Heidelberg University, Medical Faculty Mannheim, Mannheim, Germany.

Maria Garbusow (M)

Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, corporate member of FreieUniversität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Charlotte M Großkopf (CM)

Department of Psychiatry, Technische Universität Dresden, Dresden, Germany.

Marie Heigert (M)

Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, corporate member of FreieUniversität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Angela Hentschel (A)

Department of Psychiatry, Technische Universität Dresden, Dresden, Germany.

Damian Karl (D)

Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Patricia Pelz (P)

Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, corporate member of FreieUniversität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Mathieu Pinger (M)

Department of Clinical Psychology, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Carlotta Riemerschmid (C)

Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, corporate member of FreieUniversität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Annika Rosenthal (A)

Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, corporate member of FreieUniversität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Johannes Steffen (J)

Department of Psychiatry, Technische Universität Dresden, Dresden, Germany.

Jens Strehle (J)

Center for Information Services and High Performance Computing, Technische Universität Dresden, Dresden, Germany.

Franziska Weiss (F)

Department of Clinical Psychology, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Gesine Wieder (G)

Center for Information Services and High Performance Computing, Technische Universität Dresden, Dresden, Germany.

Alfred Wieland (A)

Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Judith Zaiser (J)

Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Sina Zimmermann (S)

Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Henrik Walter (H)

Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, corporate member of FreieUniversität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Bernd Lenz (B)

Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Lorenz Deserno (L)

Department of Psychiatry, Technische Universität Dresden, Dresden, Germany.
Department of Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics, University of Würzburg, Würzburg, Germany.
Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.

Michael N Smolka (MN)

Department of Psychiatry, Technische Universität Dresden, Dresden, Germany.

Shuyan Liu (S)

Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, corporate member of FreieUniversität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Ulrich W Ebner-Priemer (UW)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Heidelberg University, Medical Faculty Mannheim, Mannheim, Germany.
Mental mHealth Lab, Department of Sports and Sports Science, Karlsruhe Institute of Technology, Karlsruhe, Germany.

Andreas Heinz (A)

Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, corporate member of FreieUniversität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Michael A Rapp (MA)

Department of Social and Preventive Medicine, University of Potsdam, Potsdam, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH